@article{30105,
  keywords = {NTDs, Lymphatic filariasis, Mass drug administration, Coverage, Compliance, Diethylcarbamazine, Kalaburgi},
  author = {Biradar MK and Holyachi S},
  title = {Coverage and compliance of mass drug administration against lymphatic filariasis in Kalaburgi district.},
  abstract = {<p><strong>Background: </strong>Lymphatic filariasis (LF) is endemic in 83 countries and territories, with more than a billion people at risk of infection. Filariasis has been a major public health problem in India next only to malaria. Study was done to assess coverage and compliance of mass drug administration (MDA) against lymphatic filariasis in Kalaburgi districts. <strong>Methods: </strong>This cross-sectional coverage evaluation survey was done in one urban and three rural clusters in district. The data was compiled, tabulated and analyzed using proportions. <strong>Results: </strong>A total of 791 subjects were interviewed, male subjects constituted about 47.7%. Majority of the subjects were in the age group of 16-60 years (69.9%), while only 3.2% were in &lt;2years. 82.9% persons have received the drugs. Out of the 530 persons who have received the drugs, 86.9% persons have consumed the drugs. Only 59.9% of study subjects consumed tablets in front of health workers. A total of 69 subjects have not consumed tablets, 20.3% said told fear of side reaction, and 20.3% subjects said they don’t have faith in tablet. Only 11 persons suffered from vomiting and nausea. <strong>Conclusions: </strong>There is an urgent need for more effective drug delivery strategies and also proper IEC should be done to educate and to improve the coverage and compliance in the districts.</p>
},
  year = {2017},
  journal = {International journal of community medicine and public health},
  volume = {4},
  pages = {2502-2505},
  issn = {2394-6032},
  url = {http://www.ijcmph.com/index.php/ijcmph/article/view/1458/1271},
  doi = {10.18203/2394-6040.ijcmph20172848},
  language = {eng},
}